Evaluation of implant placement techniques for oral surgery
Clinical and Radiographic Evaluation of Equicrestal and Subcrestal Positioning of a Tissue Level Implant With Convergent Transmucosal Profile - Randomized Clinical Trial
This study is testing two different ways to place dental implants to see which method helps keep the surrounding gum and bone healthy for people getting implants.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 25 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Cagliari Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Monserrato, CA) |
| Trial ID | NCT06254885 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effects of two different implant placement techniques—equicrestal and subcrestal—on peri-implant mucosal tissues and marginal bone levels. Participants will undergo a series of preoperative, intraoperative, and postoperative procedures, including radiographs and oral hygiene instructions. The study will measure primary outcomes such as marginal bone level and Pink Esthetic Score, alongside secondary outcomes like plaque index and biological complications. Patients will be randomly assigned to one of the two implant placement groups to assess the effectiveness of each technique.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old with sufficient bone structure and good oral hygiene.
Not a fit: Patients with significant medical conditions, smokers, or those with poor oral hygiene may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve implant placement techniques, leading to better patient outcomes and reduced complications.
How similar studies have performed: Similar studies have shown promising results in evaluating different implant placement techniques, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>18 years * Absence of periodontal disease * Full mouth plaque score and full mouth bleeding score less than or equal to 25% * Sufficient bone height and width to place an implant in a prosthetically guided position without performing bone grafting procedures * Stable occlusion Exclusion Criteria: * Smokers (more than 10 cigarettes a day) * Medical conditions that contraindicate implant surgery * Pregnant and breastfeeding patients * Patients with a history of therapy with bisphosphonates or biologics * Patients undergoing chemotherapy or radiation therapy of the head and neck * Decompensated diabetes * Severe bruxism * Poor oral hygiene or uncooperative patients (incomplete data collection or failure to attend scheduled check-up appointments)
Where this trial is running
Monserrato, CA
- Policlinico Duilio Casula, AOU Cagliari — Monserrato, Ca, Italy (Recruiting)
Study contacts
- Principal investigator: Nicola Alberto Valente, DDS, MS, PhD — University of Cagliari
- Study coordinator: Nicola Alberto Valente, DDS, MS, PhD
- Email: nicola.valente@unica.it
- Phone: +393385932069
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.